Sound footing or slippery slope? The value of secondary analyses of randomized trials

J Clin Oncol. 2007 Aug 1;25(22):3191-3. doi: 10.1200/JCO.2007.11.5089.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Clinical Trials, Phase III as Topic
  • Colorectal Neoplasms / drug therapy*
  • Disease Progression
  • Empirical Research
  • Humans
  • Organoplatinum Compounds / administration & dosage*
  • Organoplatinum Compounds / adverse effects
  • Oxaliplatin
  • Randomized Controlled Trials as Topic*
  • Survival Rate
  • Time Factors
  • Treatment Outcome

Substances

  • Organoplatinum Compounds
  • Oxaliplatin